Stocks making the biggest moves midday: Travelers, SpaceX, Alphabet, Netflix, Synopsys & more

The tape is rewarding balance-sheet confidence and punishing forward-story ambiguity. In that setup, the cleanest relative winners are insurers and, selectively, banks: if reserve/credit trends stay benign, their cash generation can hold up even if the macro backdrop softens, which makes them more attractive than duration-sensitive compounders whose valuations assume uninterrupted execution. The risk is that one strong quarter gets extrapolated too far; if loss trends or funding costs mean-revert, the rerating in defensives can fade quickly.

AI infrastructure is bifurcating from AI software. Asset-backed financing for contracted compute is a real positive for companies with hard collateral and committed demand, but it also raises the bar on utilization and customer concentration: debt can accelerate growth, yet it can just as easily magnify downside if demand shifts or hardware refresh cycles shorten. By contrast, the weakness in model/app names looks less like a collapse in end demand and more like a multiple reset on delayed monetization; that argues for owning scarce infrastructure and being cautious on names where the bull case depends on opaque product momentum.

The broader message is that investors are discounting optionality more than current EPS. Pipeline disappointments and reduced transparency both trigger the same outcome: the market assigns a lower terminal multiple until management proves the next growth leg is real. In the near term, that keeps med-tech, pharma, and streaming stocks vulnerable to further de-rating even when headline numbers are fine; over 6-18 months, the names that can self-fund growth without narrative support should outperform.